Back to BlogTestosterone

Low Testosterone and Diabetes: Does Low T Cause Insulin Resistance?

Does low testosterone cause diabetes? Low T and type 2 diabetes are bidirectionally linked — low T worsens insulin resistance, and high insulin suppresses testosterone, a cycle affecting millions of men.

August 2026 9 min readManCore Editorial
Share:
ME

Written by

ManCore Editorial

ManCore Editorial

Reviewed by

ManCore Editorial Team

Sources checked against peer-reviewed literature

Last reviewed: August 2026

⚠

ManCore does not sell supplements. This article is for educational purposes only and does not constitute medical advice. Full disclaimer →

In This Article

  1. 1.Does Low Testosterone Cause Diabetes? Short Answer
  2. 2.How Low Testosterone Causes Insulin Resistance
  3. 3.How Insulin Resistance Suppresses Testosterone
  4. 4.Does TRT Improve Glucose Control?
  5. 5.Breaking the Cycle: Where to Start
  6. 6.Testing Considerations for Diabetic Men
  7. 7.Recognizing the Cycle Before It's Fully Established

Low testosterone and type 2 diabetes are linked in a bidirectional, self-reinforcing cycle that affects a large proportion of men over 40. Up to 50% of men with type 2 diabetes have low testosterone. Conversely, hypogonadal men have a 2–3× increased risk of developing T2DM. The mechanisms interconnect visceral fat, insulin signaling, SHBG, and androgen receptor function — making the two conditions almost inseparable in clinical practice.

Does Low Testosterone Cause Diabetes? Short Answer

Low testosterone raises the risk of developing type 2 diabetes and worsens insulin resistance in men who already have it — and the relationship runs in both directions, which is what makes it a genuine self-reinforcing cycle rather than a simple one-way cause [1]. Traish et al.'s review lays out the scale: roughly half of men with type 2 diabetes also have low testosterone, and men with hypogonadism carry two to three times the risk of developing type 2 diabetes compared to men with normal testosterone. Low testosterone impairs glucose uptake in muscle, promotes visceral fat accumulation, and allows inflammatory signaling that interferes with insulin receptor function; diabetes and the resulting hyperinsulinemia, in turn, directly suppress testosterone production and lower SHBG. Once this cycle is underway, each condition actively worsens the other, which is exactly why endocrinologists increasingly treat these as a connected metabolic-hormonal cluster rather than two unrelated diagnoses to manage separately.

How Low Testosterone Causes Insulin Resistance

  • •Reduced GLUT4 translocation: testosterone upregulates GLUT4 (the primary glucose transporter in muscle) — low T impairs glucose uptake
  • •Visceral fat accumulation: low T → more visceral fat → more free fatty acids → hepatic insulin resistance
  • •Reduced lean mass: less skeletal muscle = less peripheral glucose disposal = higher postprandial glucose
  • •Adiponectin reduction: low T decreases adiponectin (an insulin-sensitizing adipokine)
  • •Inflammatory cytokines: low T allows IL-6 and TNF-α to rise → interfere with insulin receptor signaling

How Insulin Resistance Suppresses Testosterone

  • •Hyperinsulinemia reduces SHBG production in liver → lowers total testosterone (though free T may be preserved initially)
  • •Hyperinsulinemia impairs Leydig cell function → reduces testicular testosterone synthesis
  • •Visceral adiposity converts T to estrogen (aromatase) → reduces T:E ratio
  • •Inflammatory environment of T2DM directly impairs LH-mediated testosterone production
  • •Net result: T2DM → low T → worsened insulin resistance → worsened T2DM

Does TRT Improve Glucose Control?

The TRAVERSE trial and multiple smaller RCTs demonstrate TRT modestly improves insulin sensitivity and HbA1c in hypogonadal men with T2DM. A 2020 meta-analysis of RCTs found TRT reduced fasting glucose and HbA1c vs. placebo. Weight loss + TRT combined produces the greatest metabolic improvement. TRT is not a substitute for diabetes medications but is an important adjunct in hypogonadal T2DM patients.

Breaking the Cycle: Where to Start

Because this is a genuinely bidirectional cycle, the most effective interventions tend to be the ones that address multiple points simultaneously rather than treating testosterone and glucose as entirely separate problems tackled one at a time. Weight loss is arguably the single highest-leverage intervention available, since visceral fat sits at the intersection of both mechanisms — reducing it directly improves insulin sensitivity and simultaneously reduces the aromatase activity that converts testosterone to estrogen, addressing both sides of the cycle at once. Resistance training compounds this benefit further by directly improving GLUT4-mediated glucose uptake in muscle, independent of weight change. For men with confirmed hypogonadism, TRT alongside these lifestyle interventions produces meaningfully better metabolic outcomes than either approach alone, based on the meta-analysis data — though TRT should be understood as an adjunct that works best when it's not the only thing being done, not a standalone fix that makes lifestyle changes unnecessary.

Testing Considerations for Diabetic Men

Given how common this overlap is, testosterone testing deserves to be a routine part of diabetes management rather than an afterthought raised only if a patient specifically brings up sexual or energy symptoms. A morning total and free testosterone, alongside SHBG, gives a clearer picture than total testosterone alone, since hyperinsulinemia's effect on SHBG can distort the total number independent of what's happening to free, biologically active testosterone. Diabetic men experiencing fatigue, reduced libido, difficulty maintaining muscle mass despite exercise, or unexplained mood changes have a reasonable case for requesting this testing explicitly if it hasn't already been part of their diabetes care, since addressing an underlying low testosterone can meaningfully improve both the metabolic and quality-of-life picture together.

Recognizing the Cycle Before It's Fully Established

The earliest, most reversible stage of this cycle is prediabetes combined with mild, not-yet-diagnosed testosterone decline — a window where both markers may still be in a borderline or early-abnormal range rather than clearly diagnostic of either condition. Men in this stage often have subtle signs on both fronts: slightly elevated fasting glucose or HbA1c that hasn't crossed into diabetic range, alongside mild fatigue, slightly reduced libido, or difficulty losing weight that hasn't yet prompted a full hormonal workup. This is precisely the stage where intervention has the highest leverage, since neither condition has had time to become deeply entrenched, and addressing body composition and insulin sensitivity aggressively at this point can prevent the self-reinforcing cycle from ever fully establishing itself. Men with a family history of type 2 diabetes, especially alongside any early low-T symptoms, are well served by requesting both a metabolic panel and a testosterone panel proactively, rather than waiting for either condition to become clearly diagnostic before taking action.

ManCore's free daily log tracks energy, libido, sleep, and mood — the symptoms most affected by low testosterone — so you can see real trends instead of guessing.

Free Tool

Track This Biomarker — Free

Don't let a number on a lab report disappear into a drawer. Log it in ManCore's biomarker tracker and watch how it trends over months as you adjust training, diet, and sleep.

Frequently Asked Questions

Does low testosterone cause diabetes?

Low testosterone increases risk of type 2 diabetes through insulin resistance mechanisms: impaired GLUT4 function, visceral fat accumulation, reduced lean mass, and increased inflammatory cytokines. Up to 50% of T2DM men have concurrent hypogonadism. TRT improves insulin sensitivity and modestly reduces HbA1c in confirmed hypogonadal T2DM patients.

Why do diabetic men have low testosterone?

T2DM suppresses testosterone through multiple pathways: hyperinsulinemia reduces SHBG and impairs Leydig cell function, visceral adiposity increases aromatase (converting T to estrogen), and the chronic inflammatory environment of T2DM directly impairs HPG axis function. This creates a bidirectional cycle where each condition worsens the other.

Will TRT help if I have diabetes and low T?

Yes — TRT in confirmed hypogonadal men with T2DM improves insulin sensitivity, reduces fasting glucose, and modestly reduces HbA1c vs. placebo in meta-analyses. TRT also reduces visceral fat (which drives insulin resistance) and increases lean muscle mass (which improves glucose disposal). Continue diabetes medications — TRT is adjunctive, not replacement therapy.

Should testosterone be tested as part of routine diabetes care?

There's a strong case for it, given that roughly half of men with type 2 diabetes have concurrent low testosterone, yet it isn't universally included in standard diabetes management panels. Diabetic men experiencing fatigue, low libido, or difficulty maintaining muscle mass have good reason to request a morning total and free testosterone panel explicitly if their diabetes care hasn't already included one.

Does type 1 diabetes have the same testosterone connection as type 2?

The connection is weaker and less consistently documented for type 1 diabetes, since type 1 is primarily an autoimmune condition affecting insulin production rather than the insulin-resistance-driven metabolic pattern that links type 2 diabetes to low testosterone through visceral fat and hyperinsulinemia. That said, men with type 1 diabetes can still develop low testosterone through other overlapping mechanisms (chronic illness burden, autoimmune conditions clustering together, medication effects), so testing isn't unreasonable, but the strong bidirectional cycle described in this article applies most specifically to type 2 diabetes.

Can reversing prediabetes prevent the testosterone-diabetes cycle from starting?

Yes, and this is one of the more actionable takeaways here — since the cycle is bidirectional and self-reinforcing once established, addressing insulin resistance at the prediabetes stage (before full type 2 diabetes develops) through weight loss and exercise is a genuine opportunity to prevent the cycle from taking hold in the first place, rather than trying to break an already-established cycle later. Men with prediabetes and any early low-T symptoms have a particularly strong case for early, aggressive lifestyle intervention, since acting at this stage is both easier and more effective than trying to reverse a fully established cycle years later, when both conditions have had time to reinforce one another.

Do diabetes medications themselves affect testosterone?

Metformin, the most commonly prescribed first-line diabetes medication, has generally neutral or even mildly favorable effects on testosterone by improving insulin sensitivity, unlike some older diabetes medications. This is a reassuring point for men worried that starting diabetes treatment might worsen their hormonal picture — properly managing blood sugar with standard first-line medications generally supports, rather than undermines, the testosterone side of this bidirectional relationship, reinforcing rather than working against the goal of breaking the cycle described throughout this article.

Does GLP-1 medication (like semaglutide) help with the testosterone-diabetes connection too?

Indirectly, yes — GLP-1 agonists produce substantial weight loss in many patients, and since visceral fat reduction is one of the core mechanisms linking diabetes and low testosterone, the significant weight loss these medications enable can meaningfully improve both insulin sensitivity and testosterone levels as a downstream effect, even though they aren't marketed or prescribed specifically as a testosterone treatment. This is an increasingly relevant consideration for men managing both conditions who haven't achieved sufficient results from diet and exercise alone.

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making changes to your health routine. Full disclaimer →

References

  1. 1.Traish AM, et al. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. J Androl. 2009;30(1):23-32. [PubMed ↗]

Put the Knowledge to Work

Track your supplements, log your symptoms, and see your health score improve — free.

Get Free Access →